Phase II evaluation of cycloleucine in the treatment of patients with disseminated sarcomas.
D000328:Adult; D000596:Amino Acids / Q000627:therapeutic use*; D003515:Cycloleucine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology
D000596:Amino Acids; D003515:Cycloleucine